Crispr Therapeutics Ag (CRSP)

$61.43 +3.59 (6.21%)
Market Cap 5.12B
Revenue (ttm) 37.31M
Net Income (ttm) -366.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -981.64%
Debt to Equity Ratio 0.00
Volume 2,548,425
Avg Vol 2,920,214
Day's Range N/A - N/A
Shares Out 90.95M
Stochastic %K 89%
Beta 1.81
Analysts Strong Sell
Price Target $81.04

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 41 561 32 77
Address:
Baarerstrasse 14, Zug, Switzerland
MarketVice
MarketVice Sep. 16 at 8:13 PM
$CRSP
0 · Reply
HodlTurtle
HodlTurtle Sep. 16 at 8:04 PM
$CRSP 4.55M volume vs. 1.82M average. This is it folks, hope y’all are ready!!
0 · Reply
shmee_19
shmee_19 Sep. 16 at 7:55 PM
$CRSP surprised you didn't average down. It was in the 30s a few months ago
0 · Reply
Antiochus_Wilson
Antiochus_Wilson Sep. 16 at 7:48 PM
$CRSP I agree! Trump is the greatest President of this generation!
1 · Reply
ItsAGreatDay
ItsAGreatDay Sep. 16 at 7:46 PM
$CRSP GO BABY, GO. Only need $86.00 to break even! One hell of a sorry ass investment!!! Ready to break even; maybe in 2026!!!
0 · Reply
EMR
EMR Sep. 16 at 7:41 PM
$CRSP Cure for political ignorance!
0 · Reply
Monsieur_Candie
Monsieur_Candie Sep. 16 at 7:40 PM
$CRSP something is cooking ?
0 · Reply
TannerTDB
TannerTDB Sep. 16 at 7:40 PM
$CRSP All of the waiting, the pain, the rollercoaster of this stock, it'll all be worth it.
0 · Reply
Darsh21
Darsh21 Sep. 16 at 7:34 PM
$CRSP what is going on! (Indian accent) 🤣
1 · Reply
Antiochus_Wilson
Antiochus_Wilson Sep. 16 at 7:25 PM
$CRSP hope it's not all Cathie... WOOD!
0 · Reply
Latest News on CRSP
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

Sep 9, 2025, 4:00 PM EDT - 7 days ago

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade.

Sep 9, 2025, 2:22 PM EDT - 7 days ago

Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade.

INCY XBI XLV

CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 11:38 AM EDT - 7 days ago

CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference Transcript

Sep 9, 2025, 6:53 AM EDT - 7 days ago

CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference Transcript

Crispr Therapeutics: A Winning Lottery Ticket Doesn't Replace Grand Strategy

Sep 2, 2025, 8:55 AM EDT - 14 days ago

Crispr Therapeutics: A Winning Lottery Ticket Doesn't Replace Grand Strategy

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Sep 2, 2025, 8:00 AM EDT - 14 days ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Crispr Therapeutics: A Speculative Buy With Promising Potential Ahead

Aug 27, 2025, 6:21 AM EDT - 20 days ago

Crispr Therapeutics: A Speculative Buy With Promising Potential Ahead

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

Aug 14, 2025, 1:02 PM EDT - 4 weeks ago

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

AMD ARKF ARKG ARKK ARKQ ARKW ARKX

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

Aug 14, 2025, 7:27 AM EDT - 4 weeks ago

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 4:15 PM EDT - 6 weeks ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

Jul 23, 2025, 11:03 AM EDT - 7 weeks ago

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

The Big 3: ASML, GOOGL, CRSP

Jul 15, 2025, 12:01 PM EDT - 2 months ago

The Big 3: ASML, GOOGL, CRSP

ASML GOOG GOOGL

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

Jul 14, 2025, 8:00 AM EDT - 2 months ago

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Jun 26, 2025, 7:00 AM EDT - 2 months ago

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

The Big 3: CRSP, OKLO, GME

Jun 23, 2025, 12:01 PM EDT - 3 months ago

The Big 3: CRSP, OKLO, GME

OKLO GME

Crispr Therapeutics: Betting On A One-Shot Future

Jun 13, 2025, 6:27 PM EDT - 3 months ago

Crispr Therapeutics: Betting On A One-Shot Future

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Jun 9, 2025, 5:50 PM EDT - 3 months ago

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

Jun 3, 2025, 4:07 PM EDT - 3 months ago

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

May 9, 2025, 7:14 AM EDT - 4 months ago

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

May 8, 2025, 8:36 AM EDT - 4 months ago

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

May 7, 2025, 4:03 PM EDT - 4 months ago

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

May 7, 2025, 2:17 PM EDT - 4 months ago

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

May 7, 2025, 8:39 AM EDT - 4 months ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

May 6, 2025, 4:01 PM EDT - 4 months ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

May 5, 2025, 4:44 AM EDT - 4 months ago

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

NTLA

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

Apr 8, 2025, 3:29 PM EDT - 5 months ago

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 8:00 AM EDT - 5 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Mar 26, 2025, 4:01 PM EDT - 6 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

CRISPR Therapeutics Set To Reach Previous Heights

Mar 25, 2025, 11:03 AM EDT - 6 months ago

CRISPR Therapeutics Set To Reach Previous Heights

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 3:28 PM EST - 7 months ago

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 8:00 AM EST - 7 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

Feb 13, 2025, 11:06 AM EST - 7 months ago

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 11, 2025, 4:01 PM EST - 7 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Feb 5, 2025, 4:16 PM EST - 7 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Feb 5, 2025, 3:48 PM EST - 7 months ago

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

Jan 15, 2025, 7:20 PM EST - 8 months ago

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 14, 2025, 7:39 PM EST - 8 months ago

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 8:30 AM EST - 8 months ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

Dec 29, 2024, 12:56 PM EST - 9 months ago

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

Dec 9, 2024, 12:00 PM EST - 10 months ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

Nov 20, 2024, 9:28 PM EST - 10 months ago

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Nov 15, 2024, 11:37 AM EST - 10 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Nov 14, 2024, 8:30 AM EST - 10 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

Nov 11, 2024, 12:54 PM EST - 11 months ago

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 9:01 AM EST - 11 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Crispr Therapeutics: Poised For A Major Turnaround

Oct 28, 2024, 6:36 AM EDT - 11 months ago

Crispr Therapeutics: Poised For A Major Turnaround

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

Oct 6, 2024, 2:00 PM EDT - 1 year ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY EDIT EXAS NTLA

Crispr Therapeutics: Prepare To Be Bored

Sep 18, 2024, 9:11 AM EDT - 1 year ago

Crispr Therapeutics: Prepare To Be Bored

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Aug 14, 2024, 6:08 AM EDT - 1 year ago

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

Aug 7, 2024, 10:41 AM EDT - 1 year ago

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

MarketVice
MarketVice Sep. 16 at 8:13 PM
$CRSP
0 · Reply
HodlTurtle
HodlTurtle Sep. 16 at 8:04 PM
$CRSP 4.55M volume vs. 1.82M average. This is it folks, hope y’all are ready!!
0 · Reply
shmee_19
shmee_19 Sep. 16 at 7:55 PM
$CRSP surprised you didn't average down. It was in the 30s a few months ago
0 · Reply
Antiochus_Wilson
Antiochus_Wilson Sep. 16 at 7:48 PM
$CRSP I agree! Trump is the greatest President of this generation!
1 · Reply
ItsAGreatDay
ItsAGreatDay Sep. 16 at 7:46 PM
$CRSP GO BABY, GO. Only need $86.00 to break even! One hell of a sorry ass investment!!! Ready to break even; maybe in 2026!!!
0 · Reply
EMR
EMR Sep. 16 at 7:41 PM
$CRSP Cure for political ignorance!
0 · Reply
Monsieur_Candie
Monsieur_Candie Sep. 16 at 7:40 PM
$CRSP something is cooking ?
0 · Reply
TannerTDB
TannerTDB Sep. 16 at 7:40 PM
$CRSP All of the waiting, the pain, the rollercoaster of this stock, it'll all be worth it.
0 · Reply
Darsh21
Darsh21 Sep. 16 at 7:34 PM
$CRSP what is going on! (Indian accent) 🤣
1 · Reply
Antiochus_Wilson
Antiochus_Wilson Sep. 16 at 7:25 PM
$CRSP hope it's not all Cathie... WOOD!
0 · Reply
JasonCO
JasonCO Sep. 16 at 7:12 PM
$CRSP nice day. locking
0 · Reply
TheProphetOfProfit
TheProphetOfProfit Sep. 16 at 7:08 PM
$CRSP recent wedge breakout on the daily, a close over $62 likely sends this higher.
0 · Reply
skcots_13
skcots_13 Sep. 16 at 6:56 PM
$CRSP Yes, of course. Who has time? But then if we never *take* time, how can we have time?
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Sep. 16 at 6:55 PM
$CRSP
0 · Reply
svertical1
svertical1 Sep. 16 at 6:53 PM
$CADL $CRSP $IBRX Sadly, the only path remaining for Short HF’s is to ramp up their manipulation strategies. More naked shorting and counterfeit shares….. until they can’t! ‘Soon’ enough! Time for SEC to wake up.
0 · Reply
T0MTrady
T0MTrady Sep. 16 at 6:52 PM
$CRSP now were talking
0 · Reply
svertical1
svertical1 Sep. 16 at 6:51 PM
$CADL $CRSP $IBRX CRSP on left, IBRX on right below.
0 · Reply
svertical1
svertical1 Sep. 16 at 6:50 PM
$IBRX $CRSP $CADL Shorts are locked in both IBRX & CRSP! Will make GME/AMC and Melvin look like child’s play. IBRX CRSP
0 · Reply
svertical1
svertical1 Sep. 16 at 6:47 PM
$CADL $CRSP $IBRX A must read article! The New Cancer paradigm is fully embraced by FDA and gaining traction. Big Pharma Chemo/radiation/poison….all old school. Much of which will one day ‘Soon’ be seen as barbaric
0 · Reply
t5776
t5776 Sep. 16 at 6:46 PM
$CRSP bet the dark pool bombs a chunk of volume at 3:55pm
0 · Reply
EMPIR3_37
EMPIR3_37 Sep. 16 at 6:43 PM
$CRSP we were 3-5 yrs away 8 days ago?
0 · Reply
svertical1
svertical1 Sep. 16 at 6:43 PM
$CRSP Trajectory to $75 looking strong!
0 · Reply